Logo image of ALEMG.PA

LABORATOIRES EUROMEDIS (ALEMG.PA) Stock Price, Quote, News and Overview

EPA:ALEMG - Euronext Paris - Matif - FR0000075343 - Common Stock - Currency: EUR

3.91  +0.03 (+0.77%)

ALEMG.PA Quote, Performance and Key Statistics

LABORATOIRES EUROMEDIS

EPA:ALEMG (5/9/2025, 7:00:00 PM)

3.91

+0.03 (+0.77%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High6.6
52 Week Low3.39
Market Cap11.22M
Shares2.87M
Float1.00M
Yearly DividendN/A
Dividend YieldN/A
PE0.88
Fwd PE8.76
Earnings (Next)10-27 2025-10-27
IPO03-27 2000-03-27


ALEMG.PA short term performance overview.The bars show the price performance of ALEMG.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20

ALEMG.PA long term performance overview.The bars show the price performance of ALEMG.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of ALEMG.PA is 3.91 EUR. In the past month the price increased by 11.08%. In the past year, price decreased by -16.09%.

LABORATOIRES EUROMEDIS / ALEMG Daily stock chart

ALEMG.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 27.99 206.28B
1ISRG.MI INTUITIVE SURGICAL INC 70.8 172.24B
IUI1.DE INTUITIVE SURGICAL INC 70.29 171.06B
BSX.DE BOSTON SCIENTIFIC CORP 38.17 135.48B
2M6.DE MEDTRONIC PLC 15.75 95.93B
SHL.DE SIEMENS HEALTHINEERS AG 21.67 54.99B
BOX.DE BECTON DICKINSON AND CO 12.04 43.30B
1BDX.MI BECTON DICKINSON AND CO 11.65 41.87B
EWL.DE EDWARDS LIFESCIENCES CORP 28.55 38.77B
DC4.DE DEXCOM INC 51.49 29.68B
PHIA.AS KONINKLIJKE PHILIPS NV 16.03 20.49B
PHI1.DE KONINKLIJKE PHILIPS NV 15.99 20.44B

About ALEMG.PA

Company Profile

ALEMG logo image Laboratoires Euromedis SA specializes in the design, manufacturing, and distribution of medical equipment. The company is headquartered in Neuilly-Sous-Clermont, Hauts-De-France and currently employs 54 full-time employees. The company went IPO on 2000-03-27. The firm specializes in the manufacturing, import, and distribution of medical equipment intended primarily for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The company also leases the equipment and provides home maintenance and hospitalization services. through a network of outlets under the Paramat name.

Company Info

LABORATOIRES EUROMEDIS

ZA de la Tuilerie

Neuilly-sous-Clermont HAUTS-DE-FRANCE FR

Employees: 190

ALEMG Company Website

ALEMG Investor Relations

Phone: 33344738360

LABORATOIRES EUROMEDIS / ALEMG.PA FAQ

What is the stock price of LABORATOIRES EUROMEDIS today?

The current stock price of ALEMG.PA is 3.91 EUR. The price increased by 0.77% in the last trading session.


What is the ticker symbol for LABORATOIRES EUROMEDIS stock?

The exchange symbol of LABORATOIRES EUROMEDIS is ALEMG and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALEMG.PA stock listed?

ALEMG.PA stock is listed on the Euronext Paris - Matif exchange.


What is LABORATOIRES EUROMEDIS worth?

LABORATOIRES EUROMEDIS (ALEMG.PA) has a market capitalization of 11.22M EUR. This makes ALEMG.PA a Nano Cap stock.


How many employees does LABORATOIRES EUROMEDIS have?

LABORATOIRES EUROMEDIS (ALEMG.PA) currently has 190 employees.


What are the support and resistance levels for LABORATOIRES EUROMEDIS (ALEMG.PA) stock?

LABORATOIRES EUROMEDIS (ALEMG.PA) has a support level at 3.47 and a resistance level at 3.92. Check the full technical report for a detailed analysis of ALEMG.PA support and resistance levels.


Is LABORATOIRES EUROMEDIS (ALEMG.PA) expected to grow?

The Revenue of LABORATOIRES EUROMEDIS (ALEMG.PA) is expected to grow by 5.19% in the next year. Check the estimates tab for more information on the ALEMG.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LABORATOIRES EUROMEDIS (ALEMG.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LABORATOIRES EUROMEDIS (ALEMG.PA) stock pay dividends?

ALEMG.PA does not pay a dividend.


When does LABORATOIRES EUROMEDIS (ALEMG.PA) report earnings?

LABORATOIRES EUROMEDIS (ALEMG.PA) will report earnings on 2025-10-27.


What is the Price/Earnings (PE) ratio of LABORATOIRES EUROMEDIS (ALEMG.PA)?

The PE ratio for LABORATOIRES EUROMEDIS (ALEMG.PA) is 0.88. This is based on the reported non-GAAP earnings per share of 4.42 and the current share price of 3.91 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ALEMG.PA.


ALEMG.PA Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to ALEMG.PA. When comparing the yearly performance of all stocks, ALEMG.PA is a bad performer in the overall market: 85.34% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ALEMG.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ALEMG.PA. ALEMG.PA has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALEMG.PA Financial Highlights

Over the last trailing twelve months ALEMG.PA reported a non-GAAP Earnings per Share(EPS) of 4.42. The EPS increased by 339.63% compared to the year before.


Industry RankSector Rank
PM (TTM) 24.05%
ROA 27.66%
ROE 57.02%
Debt/Equity 0.41
Chartmill High Growth Momentum
EPS Q2Q%89.97%
Sales Q2Q%-26.01%
EPS 1Y (TTM)339.63%
Revenue 1Y (TTM)5.58%

ALEMG.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 37% to ALEMG.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 60% and a revenue growth 5.19% for ALEMG.PA


Ownership
Inst Owners4.63%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts37.14
Price TargetN/A
EPS Next Y60%
Revenue Next Year5.19%